Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells

Journal of Neural Transmission

Volumn 117, Issue 6, 2010, Pages 793-797

  Schmidt, Andreas Johannes ^a   Clement, Hans Willi ^b   Gebhardt, Stefan ^a   Hemmeter, Ulrich Michael ^a   Schulz, Eberhard ^b   Krieg, Jürgen Christian ^a   Kircher, Tilo ^a   Heiser, Philip ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

8 Hydroxyguanine glycosylase; Atomoxetine; Psychostimulants; SH SY5Y; U 937

Indexed keywords

8 HYDROXYGUANINE; 8 HYDROXYGUANINE GLYCOSYLASE 1; AMPHETAMINE; ATOMOXETINE; DNA; ENZYME; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; CELL STRAIN SH SY5Y; CELL STRAIN U937; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; CELL LINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DNA GLYCOSYLASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METHYLPHENIDATE; MONOCYTES; NEUROBLASTOMA; PROPYLAMINES; RNA, MESSENGER;

EID: 77954541069     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0408-5     Document Type: Article

References (24)

1. AC Andreazza BN Frey B Erdtmann M Salvador F Rombaldi A Santin CA Goncalves F Kapczinski 2007 DNA damage in bipolar disorder Psychiatry Res 153 27 32 10.1016/j.psychres.2006.03.025 1:CAS:528:DC%2BD2sXhtVCmu7zO 17582509 (Pubitemid 47376945)
2. AC Andreazza BN Frey SS Valvassori C Zanotto KM Gomes CM Comim C Cassini L Stertz LC Ribeiro J Quevedo F Kapczinski M Berk CA Goncalves 2007 DNA damage in rats after treatment with methylphenidate Prog Neuropsychopharmacol Biol Psychiatry 31 1282 1288 10.1016/j.pnpbp.2007.05.012 1:CAS:528: DC%2BD2sXot12qu7k%3D 17614179 (Pubitemid 47081319)
3. ®, on the level 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder Free Rad Res 40 1003 1010 10.1080/10715760600824902 1:CAS:528:DC%2BD28XhtVCjtL3M (Pubitemid 44480565)
4. M Dizdarouglu 1991 Chemical determination of free radical-induced damage to DNA Free Rad Biol Med 10 225 242 10.1016/0891-5849(91)90080-M
5. RA El-Zein SZ Abdel-Rahman MJ Hay MS Lopez ML Bondy DL Morris MS Legator 2005 Cytogenetic effects in children treated with methylphenidate Cancer Lett 230 284 291 10.1016/j.canlet.2005.01.003 1:CAS:528:DC%2BD2MXht1aqu77K 16297714 (Pubitemid 41612471)
6. MJ Forlenza GE Miller 2006 Increased serum levels of 8-hydroxy-2- deoxyguanosine in clinical depression Psychosom Med 68 1 7 10.1097/01.psy. 0000195780.37277.2a 1:CAS:528:DC%2BD28Xmslajsg%3D%3D 16449405 (Pubitemid 43803209)
7. P Heiser S Singh JC Krieg H Vedder 2006 Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells J Psychiatr Res 40 374 379 10.1016/j.jpsychires. 2005.04.016 1:STN:280:DC%2BD283mvFCjtQ%3D%3D 16002093 (Pubitemid 43668990)
8. M Irie M Miyata H Kasai 2005 Depression and possible cancer risk due to oxidative DNA damage J Psychiatr Res 39 553 560 10.1016/j.jpsychires.2005.01.009 16005897 (Pubitemid 41278622)
9. W Jeng AW Wong R Ting-A-Kee PG Wells 2005 Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits Free Rad Biol Med 39 317 326 10.1016/j.freeradbiomed.2005.03.015 1:CAS:528:DC%2BD2MXlvVWksr0%3D 15993330 (Pubitemid 40910188)
10. MA Lovell SP Gabbita WR Markesberry 1999 Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF J Neurochem 72 771 776 10.1046/j.1471-4159.1999.0720771.x 1:CAS:528: DyaK1MXmt1ylsw%3D%3D 9930752 (Pubitemid 29055242)
11. AG Ludolph U Schaz A Storch S Liebau JM Fegert TM Boeckers 2006 Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro J Neural Transm 113 1927 1934 10.1007/s00702-006-0487-5 1:CAS:528: DC%2BD28Xht1Sgu7vE 16736241 (Pubitemid 44749635)
12. L Migliore I Fontana F Trippi R Colognato F Coppede G Tognoni B Nuccierone G Siciliano 2005 Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients Neurobiol Aging 26 567 573 10.1016/j.neurobiolaging.2004.07.016 1:CAS:528:DC%2BD2MXhtlSksLc%3D 15708428 (Pubitemid 40228745)
13. N Nishioka SE Arnold 2004 Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia Am J Geriatr Psychiatry 12 167 175 15010346
14. R Olinski D Gackowski M Foksinski R Rozalski K Roszkowski P Jaruga 2002 Oxidative DNA damage: assessment of the role in carcinogenesis, arteriosclerosis and acquired immunodeficiency syndrome Free Rad Biol Med 33 192 200 10.1016/S0891-5849(02)00878-X 1:CAS:528:DC%2BD38XmsVekt7g%3D 12106815 (Pubitemid 34775191)
15. T Peng HM Shen ZM Liu LN Yan MH Peng LQ Li RX Liang ZL Wie B Halliwell CN Ong 2003 Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China World J Gastroenterol 9 2186 2193 1:CAS:528:DC%2BD3sXpsVOjtr4%3D 14562375
16. Schmidt A, Krieg J, Clement H, Gebhardt S, Schulz E, Heiser P (2009) Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in vitro study in human neuronal and in vitro cells. J Psychopharmacol. doi: 10.1177/026988110910556 (Epub ahead of print)
17. S Selek HA Savas HS Gergerlioglu M Bulut HR Yilmaz 2008 Oxidative imbalance in adult attention deficit/hyperactivity disorder Biol Psychol 79 256 259 10.1016/j.biopsycho.2008.06.005 18644422
18. S Spahis M Vanasse SA Belanger P Ghadirian E Grenier E Levy 2008 Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder Prostaglandins Leukot Essent Fatty Acids 79 47 53 10.1016/j.plefa.2008.07.005 1:CAS:528: DC%2BD1cXhtFansbzM 18757191
19. H Stopper S Walitza A Warnke M Gerlach 2008 Brief review of available evidence concerning the potential induction of genomic damage J Neural Transm 115 331 334 10.1007/s00702-007-0829-y 1:CAS:528:DC%2BD1cXhvFygtbs%3D 17994183
20. A Valavanidis T Vlachogianni C Fiotakis 2009 8-Hydroxy-2-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27 120 139 1:CAS:528: DC%2BD1MXlsVeqtrc%3D 19412858
21. S Walitza B Werner M Romanos A Warnke M Gerlach H Stopper 2007 Does methylphenidate cause a cytogenic effect in children with attention deficit hyperactivity disorder? Environ Health Perspect 115 936 940 10.1289/ehp.9866 1:CAS:528:DC%2BD2sXnvFalt7w%3D 17589603 (Pubitemid 46902250)
22. S Walitza K Kämpf N Artamonov M Romanos R Gnana Oli S Wirth A Warnke M Gerlach H Stopper 2009 No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy Toxicol Lett 184 38 43 10.1016/j.toxlet.2008.10.011 1:CAS:528:DC%2BD1cXhsFagtrnK 19015014
23. J Wang S Xiong C Xie WR Markesberry MA Lovell 2005 Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease J Neurochem 93 953 962 10.1111/j.1471-4159.2005.03053.x 1:CAS:528:DC%2BD2MXksFKgu7o%3D 15857398 (Pubitemid 40695754)
24. F Zhou W Zhang Y Wei D Zhou Z Su X Meng L Hui W Tian 2007 The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia Leuk Res 31 387 393 10.1016/j.leukres. 2006.07.014 1:CAS:528:DC%2BD2sXltFSgsA%3D%3D 16949154 (Pubitemid 46073185)